The cost to develop new drugs and vaccines is growing and the success rate may be slowing. Likelihood of approval for new FDA Phase I
Tag: clinical trials
Report finds that rapid Covid-19 response was achieved because of IP rights, not in spite of them
Researchers’ unprecedented rapid response to the Covid-19 pandemic and that of the bio-pharmaceutical companies – which included sharing proprietary technology with many dozens of partners
ipcloseup.com 